Home LiteratureArticle Details
PMID: 6233387 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.

The Journal of experimental medicine ·Vol. 159 ·No. 6 ·1984-06-01 ·Pages 1669-85

Medof ME, Nussenzweig V

Abstract

The complement fragments C3b and C4b are the main ligands for the membrane receptor CR1. We showed elsewhere that CR1 functions as an essential cofactor for the factor I-mediated enzymatic breakdown of membrane-bound C3b (*C3b) into C3c and * C3dg . One of the main findings of the present paper is that CR1 also promotes the degradation of bound C4b (*C4b) into C4c and *C4d. On a weight basis, the cofactor activity of CR1 in the cleavage of *C4b present on the cell intermediate EAC14 is 10(3)-fold greater than that of the serum cofactor C4-binding protein ( C4bp ). An additional finding is that the effect of CR1 on either *C3b or *C4b is modulated by the presence of the other ligand in its vicinity; that is, *C4b degradation by CR1 plus I is enhanced by neighboring *C3b and vice versa. For example, upon uptake of optimal amounts of *C3b onto EAC142 and the assembly of the C3-convertase EAC1423 , the activity of CR1 in generating C4c is enhanced 5-10 times further. Conversely, when the number of *C3b molecules on EAC1423 is relatively small (or when EAC1423 has been converted by I plus H into EAC1423i ), the presence of neighboring *C4b enhances the conversion of *C3b (or *iC3b) into C3c plus * C3dg . The enhancing effect of *C3b on the cleavage of *C4b by I is observed only if the cofactor of this reaction is CR1. Indeed, the activity of I or I plus C4bp on *C4b is significantly inhibited when *C3b is fixed and the main product of the reaction is * iC4b . Taken together, these findings suggest that degradation of *C4b will be more effective when enough C3b molecules are fixed nearby, thus facilitating the interaction of *C4b*3b clusters with CR1-bearing cells, and that under physiological conditions, *C4b activity can be efficiently controlled by CR1.

MeSH Terms
Animals Buffers Complement Activating Enzymes/metabolism Complement C3-C5 Convertases/metabolism Complement C3b/physiology Complement C4/physiology Complement C4b Erythrocytes/physiology Fibrinogen/physiology Humans Immunologic Techniques Kinetics Receptors, Complement/physiology Receptors, Complement 3b Sheep/blood
Chemicals
Buffers Complement C4 Receptors, Complement Receptors, Complement 3b Complement C3b Complement C4b Fibrinogen Complement Activating Enzymes Complement C3-C5 Convertases
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Medof M E
Nussenzweig V
References (29)
29 references, click to expand
  1. The reaction mechanism of human C5 in immune hemolysis.
    J Exp Med. 1970 Oct 1;132(4):775-93 PMID: 5508377
  2. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  3. C3-mediated cytoadherence. Formation of C3 receptor aggregates as prerequisite for cell attachment.
    J Exp Med. 1975 Jul 1;142(1):242-7 PMID: 807673
  4. The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.
    Biochem J. 1978 Nov 1;175(2):675-84 PMID: 743217
  5. The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.
    J Exp Med. 1979 Aug 1;150(2):267-76 PMID: 458376
  6. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Proc Natl Acad Sci U S A. 1979 Nov;76(11):5867-71 PMID: 293688
  7. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Proc Natl Acad Sci U S A. 1979 Dec;76(12):6596-600 PMID: 293746
  8. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.
    J Immunol. 1980 Aug;125(2):578-82 PMID: 7391570
  9. Purification of the human complement control protein C3b inactivator.
    Biochem J. 1980 Oct 1;191(1):173-82 PMID: 6451220
  10. Complement receptor is an inhibitor of the complement cascade.
    J Exp Med. 1981 May 1;153(5):1138-50 PMID: 6910481
  11. Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus.
    Lancet. 1981 Sep 5;2(8245):493-7 PMID: 6115248
  12. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
    J Immunol. 1981 Oct;127(4):1348-54 PMID: 7276561
  13. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
    J Exp Med. 1982 May 1;155(5):1427-38 PMID: 6978375
  14. Competition for immune complexes by red cells in human blood.
    J Clin Lab Immunol. 1982 Jan;7(1):7-13 PMID: 7069779
  15. Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases: loss of C3b receptor antigen in focal hyalinosis and in proliferative nephritis of systemic lupus erythematosus.
    J Clin Invest. 1982 Apr;69(4):900-12 PMID: 7042757
  16. Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.
    N Engl J Med. 1982 Oct 14;307(16):981-6 PMID: 7110302
  17. Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.
    J Immunol. 1982 Nov;129(5):2051-60 PMID: 6214588
  18. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
    J Exp Med. 1982 Dec 1;156(6):1739-54 PMID: 7175439
  19. Low ionic strength or chemical cross-linking of monomeric C3b increases its binding affinity to the human complement C3b receptor.
    Immunology. 1983 Feb;48(2):229-37 PMID: 6822401
  20. Primate erythrocyte-immune complex-clearing mechanism.
    J Clin Invest. 1983 Feb;71(2):236-47 PMID: 6822663
  21. Endocytosis of the C3b receptor of complement within coated pits in human polymorphonuclear leukocytes and monocytes.
    Lab Invest. 1983 Feb;48(2):162-8 PMID: 6218336
  22. Interaction of C4-binding protein with cell-bound C4b. A quantitative analysis of binding and the role of C4-binding protein in proteolysis of cell-bound C4b.
    J Exp Med. 1983 Apr 1;157(4):1239-51 PMID: 6601177
  23. Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies.
    Arthritis Rheum. 1983 Jun;26(6):736-44 PMID: 6860375
  24. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Eur J Immunol. 1983 Jun;13(6):465-70 PMID: 6222909
  25. Alternative pathway-mediated rebinding of immune complexes to human red blood cells.
    Immunology. 1983 Sep;50(1):1-9 PMID: 6411608
  26. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
    Immunochemistry. 1966 Mar;3(2):111-35 PMID: 5960883
  27. Enharncement of the hemolytic activity of the second component of human complement by oxidation.
    J Exp Med. 1967 Dec 1;126(6):1013-25 PMID: 4964564
  28. Immune adherence by the fourth component of complement.
    Science. 1969 Jul 25;165(3891):396-8 PMID: 5815256
  29. Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cells.
    J Exp Med. 1974 Nov 1;140(5):1336-47 PMID: 4547573
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1984-06-01
Pages
1669-85
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2187328
Subset
IM
Grants
NIAID NIH HHS · AI-08499 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]